(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

In Stock•Starting at $595 for 1 mg•Purity ≥ 99.24%

CAS No.	1044535-58-1
MDL No.	N/A
MF	C₂₉H₃₀F₃N₂O₅P
MW	574.50
InChI Key	BVXLAHSJXXSWFF-KEKPKEOLSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability
1 mg	99.24%	$595	In Stock
5 mg	99.24%	$1472	In Stock
10 mg	99.24%	$2495	In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1044535-58-1
Product Name	(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

Biological Targets

NR3C1

Associated Conditions

rheumatoid arthritis

* The information provided here is compiled from public sources and is for reference only.

(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

In Stock•Starting at $595 for 1 mg•Purity ≥ 99.24%

CAS No.	1044535-58-1
MDL No.	N/A
MF	C₂₉H₃₀F₃N₂O₅P
MW	574.50
InChI Key	BVXLAHSJXXSWFF-KEKPKEOLSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability
1 mg	99.24%	$595	In Stock
5 mg	99.24%	$1472	In Stock
10 mg	99.24%	$2495	In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1044535-58-1
Product Name	(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

Biological Targets

NR3C1

Associated Conditions

rheumatoid arthritis

* The information provided here is compiled from public sources and is for reference only.

(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Will we ever have better glucocorticoids?

Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.

Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects.

(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(phosphonooxy)-7-(trifluoromethyl)-2-phenanthrenecarboxamide

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Will we ever have better glucocorticoids?

Improved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.

Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects.

Documentation